Care of Infants Born to Women with Diabetes

Sydney Peters1, Chloe Andrews2, Sarbattama Sen3,4

  • 1Tufts University, 419 Boston Avenue, Medford, MA, USA.

Insights

Infants born to mothers with diabetes face risks like hypoglycemia and congenital anomalies. Optimizing maternal glucose control and timely infant treatment are crucial for better outcomes.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Perinatal Health

Background:

  • Infants of women with diabetes are susceptible to various neonatal morbidities.
  • These include congenital anomalies, growth abnormalities, hypoglycemia, and respiratory distress.
  • Long-term outcomes and treatment advancements are areas of recent focus.

Purpose of the Study:

  • To review common neonatal morbidities in infants of diabetic mothers.
  • To discuss the pathophysiology and prevalence of these conditions.
  • To outline current treatment strategies for affected neonates.

Main Methods:

  • Literature review of recent studies on neonatal outcomes in infants of diabetic mothers.
  • Synthesis of information on pathophysiology, prevalence, and treatment.
  • Focus on advances in managing neonatal hypoglycemia and optimizing maternal glycemic control.

Main Results:

  • Optimizing maternal glycemic control is key to improving infant outcomes.
  • Despite advances, maternal diabetes remains a significant risk factor for neonatal complications.
  • Timely and appropriate treatment is essential to reduce infant morbidity.

Conclusions:

  • Infants of women with diabetes require careful monitoring and management.
  • Advances in treatment offer improved outcomes, but risks persist.
  • Continued research and clinical vigilance are necessary to mitigate neonatal morbidities.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
545
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
637